NH Korindo Sekuritas Indonesia
Menu
  • Our Service
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • About Us
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • Contact
  • Register Now
  • ID
  • EN

WIKA – Better Performance, New Contracts Still Lagging

  • Author
  • Recent Posts
Anggaraksa Arismunandar
Anggaraksa Arismunandar
Head of Research and Analyst Division
Anggaraksa Arismunandar
Latest posts by Anggaraksa Arismunandar (see all)
  • ASII – Positive Catalysts Continue - March 23, 2022
  • WIKA – Better Performance, New Contracts Still Lagging - January 12, 2022
  • SMGR – Facing Higher Costs - December 17, 2021

WIKA booked significant quarterly growth, marked by an increase in revenue (+71.7% QoQ) and net profit (+305.7% QoQ). However, high operational costs held performance from reaching its optimum, while growth mostly caused by low basis effect in the previous quarter. The company expects the continuation of some major projects to support future performance.

We downgrade our rating for WIKA to Overweight (from Buy); with a target price of IDR1,280 per share. Our target price implies 22F P/E of 14.3x (+1 SD of 3-year average). Some risks to our TP are: 1) The continuation of Covid-19 pandemic that may potentially hinder tender process and project constructions; 2) Below target new contract achievement; 3) Weakening debt level.

 

Performance Highlight

Performance-Highlight-Unilever-January-2022

Download full report HERE.

Share This Article

Related Article


Company Report | [SIDO IJ] Continuing To Widen Bottom-Line Margin, Higher Overseas Revenue, And Expand Into Younger Consumer Bases

26 Mar 2025

FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY).

Company Report | [CUAN] Acquisitions Bear Fruit, New Mine Commences

26 Mar 2025

Petrindo Jaya Kreasi (CUAN) reported an impressive 718.6% YoY rise in revenue (USD 801.7 M vs USD 97.9 M) and 929.3% increase in net income (USD 160.8 M vs USD 15.6 M) for FY24.

Company Report | [SMSS IJ] Shifting Towards Diversified CPO Derivative Products

17 Mar 2025

On a quarterly basis, 3Q24 sales declined by 19% QoQ (vs 2Q24’s 10% QoQ) as the Sales are usually weakest on the first and third quarter. In the fourth quarter, sales consistently shot up by historical evidence in 4Q23 & 4Q22 with 303% QoQ & 85% QoQ, respectively.

 

More Article

Daily Report

16 May 2025

Daily Report | 16 May 2025

The S&P 500 hovered near the flatline on Thursday, putting its three-day winning streak...

READ MORE

Daily Report

15 May 2025

Daily Report | 15 May 2025

The S&P 500 rose modestly on Wednesday, extending a strong start to the week that pushe...

READ MORE

Daily Report

14 May 2025

Daily Report | 14 May 2025

The S&P 500 rose Tuesday, clawing back into positive territory for the year, as investo...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia terdaftar dan diawasi oleh Otoritas Jasa Keuangan (OJK).


Copyright 2025 NH Korindo Sekuritas. All rights reserved.